Another COVID-19 vaccine has been added to the list of those approved by Health Canada for national use.
The AstraZeneca vaccine is the third to be given the nod by the country’s top health authorities.
Details about the vaccine’s availability for use by Canadians could be announced later on Friday.
Canada will receive up to 1.9 million doses of the AstraZeneca vaccine through a global vaccine-sharing initiative by the end of June, and Ottawa has also pre-ordered 20 million doses of the vaccine.
The Moderna and Pfizer-BioNTech vaccines are already in use in Canada and about 1.7 million doses have been administered.
The AstraZeneca vaccine requires two jabs for maximum protection, which is the same as the Pfizer and Moderna formulas.
The effectiveness of AstraZeneca is 62 per cent compared to more than 90 for Pfizer and Moderna.
Health Canada is reviewing the Johnson and Johnson vaccine and approval is not expected until June, and Novavax shots are not expected to be rubberstamped until April.